Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -177,565 | -117,148 | -52,454 | -141,965 | -94,482 |
| Depreciation Amortization | 568 | 369 | 180 | 627 | 438 |
| Accounts receivable | 1,760 | 1,760 | N/A | 8,053 | 8,053 |
| Accounts payable and accrued liabilities | -5,214 | -4,553 | -2,389 | 4,305 | 7,756 |
| Other Working Capital | -17,873 | -16,267 | -18,031 | 24,792 | 12,523 |
| Other Operating Activity | 76,887 | 51,269 | 22,671 | 26,985 | 6,970 |
| Operating Cash Flow | $-121,437 | $-84,570 | $-50,023 | $-77,203 | $-58,742 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,122 | -970 | -614 | -1,292 | -664 |
| Purchase Of Investment | -211,783 | -186,720 | -104,838 | -132,259 | -132,260 |
| Sale Of Investment | 90,457 | 66,891 | 52,769 | 70,277 | 47,446 |
| Other Investing Activity | -3,097 | 0 | 0 | -1 | -1 |
| Investing Cash Flow | $-125,545 | $-120,799 | $-52,683 | $-63,275 | $-85,479 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 232,041 | 226,667 | 219,633 | 135,973 | 129,440 |
| Financing Cash Flow | $232,041 | $226,667 | $219,633 | $135,973 | $129,440 |
| Beginning Cash Position | 38,539 | 38,539 | 38,539 | 43,044 | 43,044 |
| End Cash Position | 23,598 | 59,837 | 155,466 | 38,539 | 28,263 |
| Net Cash Flow | $-14,941 | $21,298 | $116,927 | $-4,505 | $-14,781 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,437 | -84,570 | -50,023 | -77,203 | -58,742 |
| Capital Expenditure | -1,122 | -970 | -614 | -1,292 | -664 |
| Free Cash Flow | -122,559 | -85,540 | -50,637 | -78,495 | -59,406 |